These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32614748)

  • 1. Development of Pediatric Orodispersible Tablets Based on Efavirenz as a New Therapeutic Alternative.
    de Freitas Neto JL; do Nascimento Gomes Barbosa I; de Melo CG; Ângelos MA; Dos Santos Mendes LM; Ferreira MRA; Rolim LA; Soares LAL; da Silva RMF; Neto PJR
    Curr HIV Res; 2020; 18(5):342-353. PubMed ID: 32614748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
    Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
    Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
    Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
    Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.
    Aljimaee YH; El-Helw AR; Ahmed OA; El-Say KM
    Drug Des Devel Ther; 2015; 9():1379-92. PubMed ID: 25834396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets.
    Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA
    AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Drug Delivery Strategies for Improved Therapeutic Efficacy of Efavirenz.
    Patel M; Shah R; Sawant K
    Recent Pat Nanotechnol; 2020; 14(2):119-127. PubMed ID: 31738157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin- β-Cyclodextrin Molecular Inclusion Complex: A Water-Soluble Complex in Fast-dissolving Tablets for the Treatment ofNeurodegenerative Disorders.
    Mugundhan SL; Balasubramaniyan P; Narayanasamy D; Mohan M
    Pharm Nanotechnol; 2024; 12(4):365-377. PubMed ID: 38192139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers.
    Sakr RM; Abdelaziz AES; Mazyed EA; El Maghraby GM
    Sci Rep; 2024 May; 14(1):10680. PubMed ID: 38724608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.